These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 4096107

  • 1. [Histology, normal borderline forms and pathologic proliferation patterns of the breast].
    Holzner JH.
    Verh Dtsch Ges Pathol; 1985; 69():26-50. PubMed ID: 4096107
    [No Abstract] [Full Text] [Related]

  • 2. Is 'fibrocystic disease' of the breast precancerous? A consensus report from the College of American Pathologists.
    Indiana Med; 1986 Sep; 79(9):753-4. PubMed ID: 3772069
    [No Abstract] [Full Text] [Related]

  • 3. [Definition and development of "borderline" lesions in breast cancer. Atypical hyperplasia and carcinoma "in situ"].
    Contesso G.
    J Gynecol Obstet Biol Reprod (Paris); 1980 Sep; 9(1):101-2. PubMed ID: 7451846
    [No Abstract] [Full Text] [Related]

  • 4. [Pathology, systematic aspects and classification of benign breast diseases].
    Bässler R, Kind M.
    Gynakologe; 1989 Aug; 22(4):216-25. PubMed ID: 2676756
    [No Abstract] [Full Text] [Related]

  • 5. Is 'fibrocystic disease' of the breast precancerous?
    Arch Pathol Lab Med; 1986 Mar; 110(3):171-3. PubMed ID: 3606334
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Thermography in the diagnosis of benign breast diseases].
    Lauth G, Duda V, Thein T.
    Gynakologe; 1989 Aug; 22(4):242-5. PubMed ID: 2792912
    [No Abstract] [Full Text] [Related]

  • 12. Triad of columnar cell alteration, lobular carcinoma in situ, and tubular carcinoma of the breast.
    Sahoo S, Recant WM.
    Breast J; 2005 Aug; 11(2):140-2. PubMed ID: 15730461
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cytomorphology of fibrocystic change, high-risk proliferative breast disease, and premalignant breast lesions.
    Masood S.
    Clin Lab Med; 2005 Dec; 25(4):713-31, vi. PubMed ID: 16308088
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [High-risk breast lesions].
    Bild E.
    Rev Med Chir Soc Med Nat Iasi; 1998 Dec; 102(1-2):29-35. PubMed ID: 10756809
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Variants of the morphogenesis of breast cancer].
    Danilenko VI.
    Vopr Onkol; 1984 Dec; 30(6):74-8. PubMed ID: 6741009
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Is fibrocystic disease of the breast precancerous?
    Godfrey SE.
    Arch Pathol Lab Med; 1986 Nov; 110(11):991. PubMed ID: 3778132
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.